Blood donor <scp>SARS</scp>‐<scp>CoV</scp>‐2 infection or vaccination and adverse outcomes in plasma and platelet transfusion recipients
Donor SARS-Cov-2 infection and vaccination were not associated with adverse patient outcomes and do not need to be considered in blood allocation.
Authors
- Brian Custer (ORCID: https://orcid.org/0000-0001-6251-366X)
- Nareg H. Roubinian (ORCID: https://orcid.org/0000-0002-1063-6155)
- Paula Saá (ORCID: https://orcid.org/0000-0001-6077-4532)
- Philip J. Norris (ORCID: https://orcid.org/0000-0003-0526-2088)
- Bryan R. Spencer (ORCID: https://orcid.org/0000-0002-9008-9154)
- Mars Stone (ORCID: https://orcid.org/0000-0001-5619-2767)
- Michael Paul Busch (ORCID: https://orcid.org/0000-0002-1446-125X)
- Marjorie D. Bravo (ORCID: https://orcid.org/0000-0003-3562-5556)
- Roberta Bruhn (ORCID: https://orcid.org/0000-0002-5898-8168)
- Vincent X. Liu (ORCID: https://orcid.org/0000-0001-6899-9998)
- J Greene (ORCID: https://orcid.org/0000-0002-0859-6828)
- Steve Kleinman
Institutions
- Kaiser Permanente (US)
- American Red Cross (US)
- University of British Columbia (CA)
- University of California, San Francisco (US)
- Pacific Research Institute (US)
- Vitalant (US)
- Vitalant (US)
Publication Details
- Journal
- Transfusion
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1111/trf.18159
- Citations
- 5
- Primary Topic
- Heparin-Induced Thrombocytopenia and Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 10.03
Funders
- National Heart, Lung, and Blood Institute